Kaxone SB 500mg/250mg Injection
Marketer
JM Healthcare Pvt Ltd
Salt Composition
Ceftriaxone (500mg) + Sulbactam (250mg)
Overview Kaxone SB 500mg/250mg Injection
Combiflox 500mg/250mg injection is a dual-action antibiotic indicated for diverse bacterial infections. It combats microbial growth, thereby halting infection progression. Administration must be overseen by a medical professional; strict adherence to the prescribed schedule is vital. Complete the entire course, even with symptom improvement; premature cessation may compromise efficacy. Commonly reported side effects include nausea, vomiting, diarrhea, and dyspepsia. Escalating side effects necessitate immediate medical consultation. Seek urgent medical attention for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Inform your physician of all concurrent medications, and pregnant or lactating individuals should consult their doctor before use. Alcohol should be avoided due to potential additive drowsiness. While generally non-impairing to driving ability, avoid driving if drowsiness or dizziness occurs. Sufficient rest, a balanced diet, and ample hydration will promote recovery. Your doctor may order lab tests to monitor therapeutic response.
Primary Ingredients of Kaxone SB 500mg/250mg Injection
No text provided. Please provide the text you want me to rephrase.
Uses of Kaxone SB 500mg/250mg Injection
Infections caused by bacteria
Major Benefits of Kaxone SB 500mg/250mg Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
Common Side effects of Kaxone SB 500mg/250mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Kaxone SB 500mg/250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Kaxone SB 500mg/250mg Injection works:
Ceftriaxone and Sulbactam, combined as Kaxone SB 500mg/250mg Injection, offer a dual-action approach to bacterial infection. Ceftriaxone, a crucial antibiotic component, disrupts bacterial cell wall synthesis, hindering their ability to survive. The addition of Sulbactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thus optimizing Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Kaxone SB 500mg/250mg Injection may be consumed with alcohol without adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Kaxone SB, 500mg/250mg, is typically deemed safe for use during gestation. Preclinical trials using animal models revealed minimal or no negative consequences for fetal development; however, data from human clinical trials remain scarce.
Breast feedingCAUTION
Administering Kaxone SB 500mg/250mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Kaxone SB 500mg/250mg Injection may induce drowsiness, blurred vision, and dizziness. Refrain from operating a vehicle if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Data regarding the use of Kaxone SB 500mg/250mg Injection in individuals with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
Administering Kaxone SB 500mg/250mg Injection requires careful consideration in individuals with severe hepatic impairment; dosage modification may be necessary. Medical advice is recommended. Altering the Kaxone SB 500mg/250mg Injection dosage is not advised for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Kaxone SB 500mg/250mg Injection :
Should you forget a scheduled dose of Kaxone SB 500mg/250mg Injection, seek medical advice.
Facts to Know About Kaxone SB 500mg/250mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
3,018 People bought this recently